TLR8 and neoplasm: These results collectively indicate that human tumor cells can convert responder naïve T cells into senescent T cells with suppressive functions both in vitro and in vivo and that TLR8 signaling activation in tumor cells can prevent tumor-mediated induction of T-cell senescence and subsequent immune suppression.